In a comparison of two utility stocks, FirstEnergy (FE) emerges as the superior value opportunity compared to PSEG (PEG). FE holds a Zacks Rank #2 (Buy) with a Value grade of B, while PEG has a Zacks Rank #3 (Hold) with a Value grade of C. FE's stronger earnings outlook and better valuation metrics, including a lower P/B ratio (1.8 vs 2.08) and PEG ratio (2.60 vs 2.72), position it as the more attractive investment for value investors.
FE
FirstEnergy Corp. · NYSE
Sign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about FE?
Latest news
News ›Enel Chile (ENIC) and FirstEnergy (FE) have both outperformed the broader Utilities sector year-to-date. ENIC has gained 9.5% compared to the sector's -3.2% decline, while FE returned 0.2%. Both stocks hold Zacks Rank #2 (Buy) ratings, with ENIC showing improved analyst sentiment as consensus earnings estimates rose 2.9% in the past quarter.
The Utility-Electric Power industry is positioned for growth driven by renewable energy expansion, increasing electricity consumption from AI data centers and electric vehicles, and rising electricity prices. However, higher interest rates pose financing challenges for capital-intensive utilities. Four utility stocks with Zacks Rank #2 (Buy) ratings are recommended: Entergy Corp., FirstEnergy Corp., CenterPoint Energy, and PPL Corp., all showing solid earnings growth projections and financial stability.
Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Board · $FE · 0 threads
Sign in to post on $FE
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.